TIL - Instil Bio, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
19.68 1.21 (6.15%)	---	0.41 (2.0%)	-0.11 (-0.52%)	0.0 (0.0%)	1.59 (8.14%)	-0.11 (-0.52%)	-0.11 (-0.52%)

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Market Period: Closed

Earnings & Ratios

Basic EPS:: -4.32
Diluted EPS:: -4.32
Basic P/E:: -4.8356
Diluted P/E:: -4.8356
RSI(14) 1m:: 0.0
VWAP:: 20.69
RVol:: 0.3716

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	20.89 +0.41 (+2.0%)	Oct 15 19:56
1m	Price increase 1m	20.2 +0.21 (+1.05%)	Oct 15 10:16
10m	Price increase 10m	20.2 +0.66 (+3.38%)	Oct 15 09:39